GRK2 and endothelial dysfunction: Ex vivo studies suggest the potential role of GRK2 modulation in preserving endothelium-dependent vasodilation induced by Ach during hypoxia, offering a novel treatment approach for endothelial dysfunction that is not based on drug therapies.